Evaluating Diversity in Thyroid Cancer Clinical Trials: Application of the Clinical Diversity Rating Framework
Our findings highlight the persistent underrepresentation of women, non-white racial/ethnic groups, and older adults in thyroid cancer trials. Urgent efforts are needed to address these disparities, particularly given the increasing rates of thyroid cancer among women and the healthcare access disparities in marginalized communities.
Authors
- Alicia M Koontz (ORCID: https://orcid.org/0000-0002-2222-3673)
- Haley Howard (ORCID: https://orcid.org/0000-0002-1142-8104)
- Christian Hemmerich (ORCID: https://orcid.org/0000-0002-6344-101X)
- Garrett Jones (ORCID: https://orcid.org/0000-0002-3772-4518)
- Alicia Ito Ford (ORCID: https://orcid.org/0000-0002-6866-2639)
- J. Tyler Babek (ORCID: https://orcid.org/0000-0002-4212-3792)
- Ethan Wood (ORCID: https://orcid.org/0009-0005-1562-5382)
- Matt Vassar
- J Langley
- Ryan Sherry (ORCID: https://orcid.org/0009-0000-4745-8826)
Institutions
- Oklahoma State University Medical Center (US)
- Oklahoma State University Center for Health Sciences (US)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1002/hed.28173
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88